What it is
Laparoscopy works through small ports in the abdomen with a camera and instruments; in robotic surgery the surgeon controls those instruments from a console. Endoscopic resection removes an early cancer confined to the lining through an endoscope passed by mouth, avoiding surgery altogether.
All three aim for smaller openings, less pain and faster recovery. Which one is used is decided by stage and tumour location.
Who it suits
Early stomach and colorectal cancers confined to the lining can often be dealt with entirely by endoscopic resection. Cancer that has reached the muscle layer or beyond is removed laparoscopically or robotically, together with part of the organ and its lymph nodes.
Robotic surgery is common for thyroid and prostate cancer; gynaecological cancers vary by type. The review states which resection applies and whether further tests are needed.
How it proceeds
Within about three days of arrival, endoscopy, CT and blood tests confirm the stage and the operation date is set. You are admitted the day before surgery, with an interpreter present for consent.
During your stay after the operation, diet stages and walking are scheduled and the coordinator checks on you daily. One outpatient visit follows discharge before you fly home.
Duration and recovery
A hospital stay of 2–4 nights is usual for endoscopic resection and 5–10 nights for laparoscopic or robotic resection. You fly home one to two weeks after discharge; the final pathology and whether chemotherapy is needed are explained at the outpatient visit before you leave.
Eating changes after a gastrectomy, so nutrition counselling and a multilingual guide come as standard.
Cost
Hospitals' published international prices for gastrectomy range from USD 13,900 to 22,500. Colorectal, thyroid and prostate procedures vary by hospital and method; the estimate itemises tests, surgery, admission and medication.
The review fee is credited against your bill when you go ahead with treatment.
In Korea
Stomach cancer is among the cancers most often operated on in Korea, with a five-year relative survival of 78.6% (diagnosed 2019–2023). Thyroid, colorectal and prostate resections are also high-volume, with standardised pathways.
Hospital names and results are not listed; the opinion compares three hospitals for you.
Frequently asked questions
- Is robotic surgery better than laparoscopy?
- It depends on the organ and the stage. In the narrow pelvis (prostate, rectum) the robot's advantages are significant; for many stomach and colon cases laparoscopy is enough. Costs differ, so the opinion sets out both.
- What if chemotherapy is needed after surgery?
- That is decided by the final pathology. If it is needed, we propose either starting the first cycle in Korea and continuing at home, or extending your stay — with an estimate for each.
- How long should I plan to stay?
- About 10 days for endoscopic resection, and 2–3 weeks for laparoscopic or robotic resection. Family accommodation is arranged within walking distance of the hospital.
Clinical trials recruiting in Korea auto-updated · 2026-09-29
Fetched daily from ClinicalTrials.gov. Whether you can take part is answered in the opinion, based on stage.
| NCT | Phase | Sponsor | Updated |
|---|---|---|---|
| A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478 | PHASE2 | Daiichi Sankyo | 2026-09-25 |
| Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors NCT06005493 | PHASE1/PHASE2 | AstraZeneca | 2026-09-25 |
| A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers NCT06663319 | PHASE1 | Janssen Research & Development, LLC | 2026-09-25 |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer NCT06901531 | PHASE3 | Astellas Pharma Global Development, Inc. | 2026-09-24 |
| Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor NCT05523947 | PHASE1/PHASE2 | Yuhan Corporation | 2026-09-24 |
| Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) NCT05489211 | PHASE2 | AstraZeneca | 2026-09-23 |
Recent literature auto-updated · 2026-09-29
Review articles from the last five years, fetched daily from PubMed.
- Effectiveness of Enhanced Recovery After Surgery Protocols for Robot Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis. — Journal of laparoendoscopic & advanced surgical techniques. Part A, 2026
- Comparative Outcomes of Transoral Robotic Surgery Versus Open Surgery in Head and Neck Cancer: A Systematic Review and Meta-Analysis. — Cureus, 2026
- Low-pressure pneumoperitoneum in robot-assisted radical prostatectomy: a systematic review, meta-analysis and trial sequential analysis of randomized controlled trials. — International urology and nephrology, 2026
- Laparoscopic versus robotic surgery for colorectal cancer: an updated meta-analysis with comparison against published systematic reviews. — Journal of robotic surgery, 2026
- Global research trends and thematic evolution in salvage robot-assisted radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy: a bibliometric and visualisation study. — Journal of robotic surgery, 2026
- Robot-assisted versus laparoscopic surgery for rectal cancer: a systematic review and meta-analysis of randomised trials with GRADE certainty rating. — Surgical endoscopy, 2026
Related cancers
Statistics on this page are official national statistics, not the results of any particular hospital. Outcomes differ by stage and by individual health. Discuss diagnosis and treatment decisions with your physicians.